Informations dans le contexte du COVID-19
- 08/07/2020: Supervisory expectations on Product Oversight and Governance requirements amidst the COVID-19 situation
- 02/04/2020: Typologies COVID-19 établies par la Cellule de Renseignement Financier
- 02/04/2020: EIOPA urges (re)insurers to temporarily suspend all discretionary dividend distributions and share buy backs
- 02/04/2020: Calendriers 2020 adaptés des Reportings (SOLO) au CAA au vu de la crise sanitaire actuelle et de ses incidences sur le fonctionnement normal des entités soumises à la surveillance prudentielle du CAA
- 02/04/2020: Note d’information relative à la prorogation des délais de remise du reporting national annuel et trimestriel dans le contexte COVID-19
- 01/04/2020: Statement by the FATF President: COVID-19 and measures to combat illicit financing
- 01/04/2020: EIOPA urges insurers and intermediaries to continue to take actions to mitigate the impact of Coronavirus/COVID-19 on consumers
- 27/03/2020: EIOPA publishes extraordinary information for Solvency II Relevant Risk Free Interest Rate Term Structures and Symmetric Adjustment to Equity Risk with reference to 24 March 2020
- 25/03/2020: Note d’information du Commissariat aux Assurances relative aux recommandations de l’EIOPA sur un allongement des délais de remise du reporting Solvabilité2 dans le contexte COVID-19
- 20/30/2020: EIOPA issues Recommendations on supervisory flexibility regarding deadlines of supervisory reporting and public disclosure by insurers
- 17/03/2020: Mesures prises par le CAA
- 17/03/2020: EIOPA statement on actions to mitigate the impact of Coronavirus/COVID-19 on the EU insurance sector